Deerfield Management’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,411,000
Closed -$38.8M 132
2024
Q4
$38.8M Hold
1,411,000
0.73% 34
2024
Q3
$40.6M Hold
1,411,000
0.61% 34
2024
Q2
$35M Hold
1,411,000
0.58% 38
2024
Q1
$45.4M Buy
1,411,000
+788,888
+127% +$29.3M 0.79% 31
2023
Q4
$25.3M Buy
+622,112
New +$22.9M 0.47% 43
2021
Q3
Sell
-657,005
Closed -$45.3M 142
2021
Q2
$45.3M Buy
+657,005
New +$50.1M 0.8% 40
2019
Q4
Sell
-101,010
Closed -$15.4M 86
2019
Q3
$15.4M Hold
101,010
0.63% 50
2019
Q2
$13M Sell
101,010
-75,948
-43% -$9.01M 0.47% 64
2019
Q1
$20.8M Sell
176,958
-111,449
-39% -$11.2M 0.8% 41
2018
Q4
$26.5M Buy
288,407
+28,343
+11% +$2.87M 1.06% 36
2018
Q3
$29.2M Buy
260,064
+95,064
+58% +$10M 1.05% 36
2018
Q2
$15.2M Buy
165,000
+35,000
+27% +$3.4M 0.53% 69
2018
Q1
$13M Hold
130,000
0.45% 75
2017
Q4
$12.2M Hold
130,000
0.48% 61
2017
Q3
$13.2M Sell
130,000
-57,501
-31% -$5.02M 0.6% 56
2017
Q2
$14.3M Sell
187,501
-72,267
-28% -$6.08M 0.77% 37
2017
Q1
$22.4M Sell
259,768
-163,344
-39% -$11.8M 0.86% 43
2016
Q4
$27.2M Hold
423,112
1.12% 33
2016
Q3
$27.4M Sell
423,112
-35,000
-8% -$1.97M 1.27% 27
2016
Q2
$25.4M Buy
458,112
+130,486
+40% +$6.56M 1% 38
2016
Q1
$13.7M Buy
327,626
+144,626
+79% +$6.71M 0.58% 50
2015
Q4
$11.5M Sell
183,000
-258,085
-59% -$13.2M 0.47% 62
2015
Q3
$18M Sell
441,085
-201,523
-31% -$11.6M 0.69% 52
2015
Q2
$33.1M Buy
+642,608
New +$34.1M 1.1% 30

Other funds holding LKFT

Deerfield Management's LKFT Position: Q1 2025 in Review

Deerfield Management sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2025, closing a stake of 1,411,000 shares — an estimated $38.8M sold.

Deerfield Management first reported a position in LKFT in Q2 2015 and held it in 24 quarters. The position peaked at $45.4M in Q1 2024. 83 funds tracked by Wall St. Rank hold LKFT as of Q1 2025.

  • Deerfield Management reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2025 after selling out during the quarter.
  • Deerfield Management sold 1,411,000 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2025, an estimated $38.8M.
  • Deerfield Management first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2015 and held it in 24 quarters.
  • Deerfield Management's Lakefront Biotherapeutics American Depositary Shares position peaked at $45.4M in Q1 2024.
  • 83 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2025.

Based on Deerfield Management's 13F filing for Q1 2025, filed 15 May 2025.